These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12630756)

  • 61. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibodies to prothrombin in patients with Sneddon's syndrome.
    Kalashnikova LA; Korczyn AD; Shavit S; Rebrova O; Reshetnyak T; Chapman J
    Neurology; 1999 Jul; 53(1):223-5. PubMed ID: 10408567
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Antiprothrombin antibodies in a patient with secondary antiphospholipid syndrome and bleeding].
    González León R; García Hernández FJ; Castillo Palma MJ; Sánchez Román J
    Med Clin (Barc); 2011 Nov; 137(14):668-9. PubMed ID: 21507436
    [No Abstract]   [Full Text] [Related]  

  • 65. [A study on antiprothrombin antibodies in antiphospholipid syndrome].
    Ieko M; Triplett DA; Kohno M; Ohmoto A; Notoya A; Sawada K; Koike T
    Rinsho Ketsueki; 1997 May; 38(5):426-32. PubMed ID: 9194388
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
    Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
    Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 70. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
    Dima A; Caraiola S; Jurcut C; Balanescu E; Balanescu P; Ramba D; Badea C; Pompilian V; Ionescu R; Baicus A; Baicus C; Dan GA
    Rom J Intern Med; 2015; 53(4):321-8. PubMed ID: 26939208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
    Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
    Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus.
    Spadaro A; Riccieri V; Terracina S; Rinaldi T; Taccari E; Zoppini A
    Lupus; 2000; 9(1):56-60. PubMed ID: 10713647
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Pittoni M; Bontadi A; Tonello M; Salvan E; Plebani M; Punzi L
    Clin Chim Acta; 2012 May; 413(9-10):911-3. PubMed ID: 22349599
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus.
    Palomo I; Pereira J; Alarcon M; Larrain AM; Pinochet C; Vasquez M; Velez MT; Leon M; Espinola R; Pierangeli S
    J Lab Clin Med; 2002 Nov; 140(5):336-41. PubMed ID: 12434135
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome.
    Erkan D; Zhang HW; Shriky RC; Merrill JT
    Lupus; 2002; 11(4):215-20. PubMed ID: 12043884
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies.
    Horbach DA; van Oort E; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Apr; 79(4):790-5. PubMed ID: 9569194
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
    Naarendorp M; Spiera H
    J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.